Nesina and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Nesina (alogliptin benzoate), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Amaryl, and have Diabetes.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Nesina. It is created by eHealthMe based on reports of 2,291 people who have side effects when taking Nesina from the FDA, and is updated regularly.

What is Nesina?

Nesina has active ingredients of alogliptin benzoate. eHealthMe is studying from 2,297 Nesina users. Check the latest studies of Nesina.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,578 drugs and 4,588 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

On Jul, 09, 2026

2,291 people reported to have side effects when taking Nesina.
Among them, 74 people (3.23%) have Appetite - decreased.

Could Nesina cause Appetite - decreased?

Among these 74 people:

How long have people been on Nesina when they have Appetite - decreased? *

What is the gender of people who have Appetite - decreased when taking Nesina? *

female: 41.54 %
male: 58.46 %

What is the age of people who have Appetite - decreased when taking Nesina? *

What are other drugs people take besides Nesina? *

Amaryl: 10 people, 13.51%
Blopress: 9 people, 12.16%
Zantac: 7 people, 9.46%
Sutent: 7 people, 9.46%
Rebetol: 6 people, 8.11%
Diovan: 6 people, 8.11%
Metformin Hydrochloride: 5 people, 6.76%
Amlodipine: 4 people, 5.41%
Caduet: 4 people, 5.41%
Novorapid: 4 people, 5.41%

What are other side effects people have besides Appetite - decreased? *

Nausea (feeling of having an urge to vomit): 21 people, 28.38%
Malaise (a feeling of general discomfort or uneasiness): 21 people, 28.38%
Nausea And Vomiting: 12 people, 16.22%
Thrombocytopenia (decrease of platelets in blood): 12 people, 16.22%
Anaemia (lack of blood): 11 people, 14.86%
Fever: 11 people, 14.86%
Dizziness: 11 people, 14.86%
Diarrhea: 10 people, 13.51%
Dehydration (dryness resulting from the removal of water): 10 people, 13.51%
Weight Decreased: 9 people, 12.16%

What are the existing conditions these people have? *

Diabetes: 44 people, 59.46%
High Blood Pressure: 16 people, 21.62%
Type 2 Diabetes: 9 people, 12.16%
Gastrointestinal Stromal Tumor: 7 people, 9.46%
Constipation: 6 people, 8.11%
Hepatitis C: 6 people, 8.11%
Insomnia (sleeplessness): 6 people, 8.11%
Dyslipidaemia (abnormal amount of lipids): 5 people, 6.76%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 6.76%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Nesina and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nesina:

Nesina (2,297 reports)

Browse all side effects of Nesina:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,578 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,588 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alogliptin benzoate (the active ingredients of Nesina) and Nesina (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.